Parosanu相关文献与解析，生知库 | 链接生命科学的每一步

Metastatic Kidney Cancer: Does the Location of the Metastases Matter? Moving towards Personalized Therapy for Metastatic Renal Cell Carcinoma

转移性肾癌：转移部位重要吗？迈向转移性肾细胞癌的个体化治疗

期刊:Biomedicines

影响因子:3.9

doi:10.3390/biomedicines12051111

Baston, Catalin; Parosanu, Andreea Ioana; Stanciu, Ioana-Miruna; Nitipir, Cornelia

Tumor-to-Tumor Metastasis of Lung Cancer to Kidney Cancer: A Review of the Literature and Our Experience

肺癌向肾癌的肿瘤间转移：文献回顾及我们的经验

期刊:Diagnostics

影响因子:3.3

doi:10.3390/diagnostics14050553

Baston, Catalin; Parosanu, Andreea Ioana; Mihai, Mihaela; Moldoveanu, Oana; Stanciu, Ioana Miruna; Nitipir, Cornelia

An Overview of the Safety Profile and Clinical Impact of CDK4/6 Inhibitors in Breast Cancer-A Systematic Review of Randomized Phase II and III Clinical Trials

CDK4/6抑制剂在乳腺癌中的安全性和临床影响概述——随机II期和III期临床试验的系统评价

期刊:Biomolecules

影响因子:4.8

doi:10.3390/biom13091422

Stanciu, Ioana-Miruna; Parosanu, Andreea Ioana; Nitipir, Cornelia

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma

中性粒细胞与淋巴细胞比值在转移性肾细胞癌患者中的预后价值

期刊:Current Oncology

影响因子:3.4

doi:10.3390/curroncol30020187

Parosanu, Andreea Ioana; Pirlog, Cristina Florina; Slavu, Cristina Orlov; Stanciu, Ioana Miruna; Cotan, Horia-Teodor; Vrabie, Radu Constantin; Popa, Ana-Maria; Olaru, Mihaela; Iaciu, Cristian; Bratu, Lucian Ioan; Baicoianu, Ionut Florian; Moldoveanu, Oana; Baston, Catalin; Nițipir, Cornelia

Second-Line Treatment of Metastatic Renal Cell Carcinoma in the Era of Predictive Biomarkers

预测性生物标志物时代转移性肾细胞癌的二线治疗

期刊:Diagnostics

影响因子:3.3

doi:10.3390/diagnostics13142430

Parosanu, Andreea Ioana; Baston, Catalin; Stanciu, Ioana Miruna; Parlog, Cristina Florina; Nitipir, Cornelia

Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer-A Review of the Literature

CDK4/6抑制剂耐药机制及HR+/HER2-转移性乳腺癌疗效预测生物标志物——文献综述

期刊:Diagnostics

影响因子:3.3

doi:10.3390/diagnostics13050987

Stanciu, Ioana-Miruna; Parosanu, Andreea Ioana; Orlov-Slavu, Cristina; Iaciu, Ion Cristian; Popa, Ana Maria; Olaru, Cristina Mihaela; Pirlog, Cristina Florina; Vrabie, Radu Constantin; Nitipir, Cornelia

Impact of Patient Profile on CDK4/6 Inhibitor Therapy Outcomes: A Real-World Data Analysis

患者特征对 CDK4/6 抑制剂治疗结果的影响：一项真实世界数据分析

Early-Stage Renal Cell Carcinoma: Who Needs Adjuvant Therapy?

早期肾细胞癌：哪些患者需要辅助治疗？

Sarcopenia in Urothelial Bladder Carcinoma: A Narrative Review

尿路上皮膀胱癌患者的肌少症：叙述性综述

Perspectives on Adrenal Tumor Surgery

肾上腺肿瘤手术的展望

Metastatic Kidney Cancer: Does the Location of the Metastases Matter? Moving towards Personalized Therapy for Metastatic Renal Cell Carcinoma

转移性肾癌：转移部位重要吗？迈向转移性肾细胞癌的个体化治疗

Tumor-to-Tumor Metastasis of Lung Cancer to Kidney Cancer: A Review of the Literature and Our Experience

肺癌向肾癌的肿瘤间转移：文献回顾及我们的经验

An Overview of the Safety Profile and Clinical Impact of CDK4/6 Inhibitors in Breast Cancer-A Systematic Review of Randomized Phase II and III Clinical Trials

CDK4/6抑制剂在乳腺癌中的安全性和临床影响概述——随机II期和III期临床试验的系统评价

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma

中性粒细胞与淋巴细胞比值在转移性肾细胞癌患者中的预后价值

Second-Line Treatment of Metastatic Renal Cell Carcinoma in the Era of Predictive Biomarkers

预测性生物标志物时代转移性肾细胞癌的二线治疗

Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer-A Review of the Literature

CDK4/6抑制剂耐药机制及HR+/HER2-转移性乳腺癌疗效预测生物标志物——文献综述